China’s CMDE Drafts Guidelines for the Registration of Implantable Medical Devices


On January 2023, the CMDE issued Chinese regulators issue regulations for enterprises’ management of medical device safety, plus draft guidelines for the registration and review of implantable medical device batteries.


In order to urge medical device registrants and filers to implement the main responsibility for the quality and safety of medical devices, The China National Medical Products Administration (NMPA) and Center for Medical Device Evaluation (CMDE) published new rules for the supervision and management of enterprises implementing medical device safety, as well as draft guidelines for the registration and review of implantable medical device batteries.

Specification applies for:

  • It will go into effect March 1, 2023
  • Registrants and record filers must ensure the quality and safety of medical devices.
  • The Interpretation of the Regulations on the Supervision and Management of Companies Implementing Primary Responsibility for the Quality and Safety of Medical Devices further discusses the provisions of the Regulations.
  • The CMDE notice opening the public consultation of the draft Guidelines, which will standardize the technical review requirements and provide guidance for the application/registration of enterprises.
  • Comments or suggestions must be sent via email before January 6, 2023.

Learn More

Brochure: committed to your success in china

We are a global consulting firm that provides local representation, Regulatory Affairs, Quality, Clinical and Safety through our local offices. We service pharmaceutical, biotech, and life consumer companies worldwide in China.

GRP can act as your local Agent & Register your product in China

Contact our team today to Inquire!


Telephone : (+1) 781-672-4200


Learn more about NMPA. For the link, click here (Only available in Chinese).

About Global Regulatory Partners

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices, pharmaceutical, cosmetic and Food Supplement companies globally.

GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and South Korea. GRP helps many life science companies register their products in different countries in compliance with local regulations. 

Follow GRP on Social Media !

Subscribe to our Blogs & Newsletter

Share This Post: